These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8485913)
1. Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers. Dauchel H; Joly P; Delpech A; Thomine E; Sauger F; Le Loet X; Lauret P; Tron F; Fontaine M; Ripoche J Clin Exp Immunol; 1993 May; 92(2):274-83. PubMed ID: 8485913 [TBL] [Abstract][Full Text] [Related]
2. Membrane attack complex of complement in leukocytoclastic vasculitis of the skin. Presence and possible pathogenetic role. Boom BW; Out-Luiting CJ; Baldwin WM; Westedt ML; Daha MR; Vermeer BJ Arch Dermatol; 1987 Sep; 123(9):1192-5. PubMed ID: 3632003 [TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of the terminal complement complex in patients with evidence of complement activation. Mollnes TE; Frøland SS; Harboe M Complement; 1985; 2(2-3):175-84. PubMed ID: 3878765 [TBL] [Abstract][Full Text] [Related]
4. C3d,g is present in normal human epidermal basement membrane. Basset-Seguin N; Dersookian M; Cehrs K; Yancey KB J Immunol; 1988 Aug; 141(4):1273-80. PubMed ID: 3135326 [TBL] [Abstract][Full Text] [Related]
5. Leukocytoclastic vasculitis in association with linear epidermal basement membrane zone immunoglobulin deposition: Linear vasculitis. Magro CM; Mo JH; Kerns MJ Clin Dermatol; 2022; 40(6):639-650. PubMed ID: 35907580 [TBL] [Abstract][Full Text] [Related]
6. Early- and late-phase activation of complement evaluated by plasma levels of C3d,g and the terminal complement complex. Mollnes TE Complement; 1985; 2(2-3):156-64. PubMed ID: 3878764 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda. Vasil KE; Magro CM J Am Acad Dermatol; 2007 Jan; 56(1):96-104. PubMed ID: 17190626 [TBL] [Abstract][Full Text] [Related]
8. Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis. Garred P; Lyon H; Christoffersen P; Mollnes TE; Tranum-Jensen J Liver; 1993 Dec; 13(6):305-10. PubMed ID: 7507546 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall. Takatu CM; Heringer APR; Aoki V; Valente NYS; de Faria Sanchez PC; de Carvalho JF; Criado PR Immunol Res; 2017 Feb; 65(1):395-401. PubMed ID: 27530606 [TBL] [Abstract][Full Text] [Related]
10. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Gerl VB; Bohl J; Pitz S; Stoffelns B; Pfeiffer N; Bhakdi S Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1104-8. PubMed ID: 11923252 [TBL] [Abstract][Full Text] [Related]
11. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g. Davis AE; Harrison RA; Lachmann PJ J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952 [TBL] [Abstract][Full Text] [Related]
12. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes. Garred P; Michaelsen TE; Aase A; Mollnes TE J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791 [TBL] [Abstract][Full Text] [Related]
13. In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin. Bahia El Idrissi N; Iyer AM; Ramaglia V; Rosa PS; Soares CT; Baas F; Das PK PLoS One; 2017; 12(5):e0177815. PubMed ID: 28505186 [TBL] [Abstract][Full Text] [Related]
14. C3d,g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation. Basset-Séguin N; Porneuf M; Dereure O; Mils V; Tesnières A; Yancey KB; Guilhou JJ J Invest Dermatol; 1993 Dec; 101(6):827-31. PubMed ID: 8245511 [TBL] [Abstract][Full Text] [Related]
15. Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin. French LE; Polla LL; Tschopp J; Schifferli JA J Invest Dermatol; 1992 May; 98(5):758-63. PubMed ID: 1569324 [TBL] [Abstract][Full Text] [Related]
16. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. Magro CM; Dyrsen ME J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098 [TBL] [Abstract][Full Text] [Related]
17. Semiologic value of C1q and C4 cutaneous deposits. An immunofluorescent study. Gomes MA; Fernandez-Bussy R; Ohrt C; Thivolet J J Cutan Pathol; 1982 Jun; 9(3):169-74. PubMed ID: 6752226 [TBL] [Abstract][Full Text] [Related]
18. Demonstration of C3d and the terminal complement complex on thymic large granular lymphocytes and common thymocytes after incubation with naturally thymocytotoxic serum. Sandberg G; Stenvinkel C; Mollnes TE Int Arch Allergy Appl Immunol; 1988; 87(3):239-46. PubMed ID: 3264545 [TBL] [Abstract][Full Text] [Related]
19. Studies of C3d,g in normal human epidermal basement membrane. Yancey KB; Basset-Séguin N J Invest Dermatol; 1990 Jun; 94(6 Suppl):122S-127S. PubMed ID: 2191048 [TBL] [Abstract][Full Text] [Related]
20. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis]. Hou J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]